Scientific information

Dear Doctors,

The aim of this section is to support your daily work with pregnant women and to inspire you to talk to them about cord blood and cord tissue banking, as well as to keep you  up to date on the current status of stem cell applications in medicine.

Thanks to our cooperation with medical specialists, Polski Bank Komórek Macierzystych is well informed of current medical news from around the world. We work with a number of scientific societies and transplant clinics. This section is dedicated to those interested in the current status of stem cells extracted from cord blood, as well as to doctors interested in the current status and progressions of cord blood applications in medical therapies.

Basic information on umbilical cord blood

The content of the material was reviewed by experts of the Polish Society of Paediatric Oncology and Haematology. The material was prepared for the XXXI Polish Association Congress.

Opinion of Polish Society of Pediatric Oncology and Hematology

The opinion on cord blood collection postulated by the Polish Gynaecological Society regarding the collection and storage of stem cells from cord blood

The Polish Gynaecological Society approves of cord blood banking in any form and grants women  the freedom of decision-making.

Opinion of Polish Gynaecological Society

Publication specific to the first autologous cord blood transplant performed in Poland

The blood was stored at the Polish Stem Cell Bank and used for transplantation thanks  to the collaboration of scientists from PAN and clinisists from the Children’s Health Centre.

Autologous Transplant from Cord Blood derived Stem Cells

Current statistics on the use and effectiveness of stem cells in therapies in the USA

The statistics can be viewed here:

Registry of research studies currently underway

Type in “cord blood stem cells” in the search engine

Transplanting Stem Cells Works for Scleroderma

Clinical trial showed how autologous blood stem cell transplants significantly improved survival in patients with high-risk scleroderma.